Lesion Quantification Accuracy of Digital


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
02 2023
Historique:
received: 30 04 2022
revised: 13 08 2022
pubmed: 19 8 2022
medline: 4 2 2023
entrez: 18 8 2022
Statut: ppublish

Résumé

Therapy with

Identifiants

pubmed: 35981898
pii: jnumed.122.264338
doi: 10.2967/jnumed.122.264338
pmc: PMC9902858
doi:

Substances chimiques

Yttrium Radioisotopes 0
Gallium Radioisotopes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-336

Informations de copyright

© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Front Oncol. 2014 Feb 27;4:38
pubmed: 24579065
Clin Nucl Med. 2021 Aug 1;46(8):641-646
pubmed: 33883494
Cancer Biother Radiopharm. 2015 Jun;30(5):200-10
pubmed: 25860616
EJNMMI Phys. 2021 Feb 15;8(1):14
pubmed: 33587222
J Nucl Med. 2000 Oct;41(10):1673-81
pubmed: 11037997
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2507-2515
pubmed: 32424483
Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1654-62
pubmed: 20422185
Sci Rep. 2021 Sep 1;11(1):17477
pubmed: 34471170
Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):611-23
pubmed: 17929014
Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):354-61
pubmed: 12634962
BMC Cancer. 2021 Jan 14;21(1):62
pubmed: 33446147
Pharmaceuticals (Basel). 2021 Nov 24;14(12):
pubmed: 34959613
Clin Cancer Res. 2022 Oct 3;28(19):4346-4353
pubmed: 35833949
EJNMMI Phys. 2016 Dec;3(1):17
pubmed: 27495914
Z Med Phys. 2011 Dec;21(4):281-9
pubmed: 21983023
Clin Nucl Med. 2021 Oct 1;46(10):842-844
pubmed: 34392291
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1767-1769
pubmed: 34877610
EJNMMI Phys. 2019 Aug 5;6(1):16
pubmed: 31385052
EJNMMI Res. 2021 Feb 28;11(1):21
pubmed: 33641046
Front Oncol. 2013 Aug 19;3:215
pubmed: 23967404
Med Phys. 2019 Dec;46(12):5403-5406
pubmed: 31584697
PLoS One. 2021 Feb 10;16(2):e0246848
pubmed: 33566845
PLoS One. 2013;8(2):e55742
pubmed: 23405207
J Nucl Med. 2005 Jun;46(6):1023-7
pubmed: 15937315
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Clin Nucl Med. 2021 Nov 1;46(11):e523-e530
pubmed: 34269729
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Phys Med Biol. 2010 Apr 21;55(8):2365-98
pubmed: 20360631
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1202-22
pubmed: 25967868
Phys Med. 2020 Dec;80:317-326
pubmed: 33248338
EJNMMI Phys. 2020 Mar 4;7(1):14
pubmed: 32130554
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2395-2404
pubmed: 33797596
EJNMMI Phys. 2021 Jul 27;8(1):56
pubmed: 34318383
J Nucl Med. 2010 Dec;51(12):1969-73
pubmed: 21078802
Q J Nucl Med Mol Imaging. 2023 Mar;67(1):57-68
pubmed: 34309334
J Nucl Med. 2022 May;63(5):727-734
pubmed: 34385340
J Nucl Med. 2019 Jul;60(7):1031-1036
pubmed: 30630944
Appl Radiat Isot. 2020 Feb;156:108942
pubmed: 31671334
Biomed Res Int. 2015;2015:481279
pubmed: 26106608
Appl Radiat Isot. 2007 Mar;65(3):318-27
pubmed: 17045483
EJNMMI Phys. 2016 Dec;3(1):11
pubmed: 27387738
PLoS One. 2015 Mar 16;10(3):e0116683
pubmed: 25775399

Auteurs

David Kersting (D)

Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany; david.kersting@uni-due.de.
German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.

Walter Jentzen (W)

Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.

Daniel Jeromin (D)

Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.

Ilektra-Antonia Mavroeidi (IA)

German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Department of Medical Oncology, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Maurizio Conti (M)

Siemens Medical Solutions USA, Inc., Knoxville, Tennessee; and.

Florian Büther (F)

Department of Nuclear Medicine, University Hospital Muenster, University of Muenster, Muenster, Germany.

Ken Herrmann (K)

Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.

Christoph Rischpler (C)

Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.

Rainer Hamacher (R)

German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Department of Medical Oncology, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Wolfgang P Fendler (WP)

Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.

Robert Seifert (R)

Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Department of Nuclear Medicine, University Hospital Muenster, University of Muenster, Muenster, Germany.

Pedro Fragoso Costa (PF)

Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH